​
​

Vicarious Surgical (RBOT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

RBOT Stock Forecast

Vicarious Surgical stock forecast is as follows: an average price target of $8.75 (represents a -4.37% downside from RBOT’s last price of $9.15) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

RBOT Price Target

The average price target for Vicarious Surgical (RBOT) is $8.75 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $10.50 to $7.00. This represents a potential -4.37% downside from RBOT's last price of $9.15.

RBOT Analyst Ratings

Buy

According to 3 Wall Street analysts, Vicarious Surgical's rating consensus is 'Buy'. The analyst rating breakdown for RBOT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Vicarious Surgical Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 13, 2024Adam MaederPiper Sandler$10.50$6.0772.98%14.75%
Jul 18, 2022-BTIG$7.00$3.50100.00%-23.50%
May 10, 2022-Piper Sandler$5.00$3.5640.45%-45.36%
Row per page
Go to

The latest Vicarious Surgical stock forecast, released on Nov 13, 2024 by Adam Maeder from Piper Sandler, set a price target of $10.50, which represents a 72.98% increase from the stock price at the time of the forecast ($6.07), and a 14.75% increase from RBOT last price ($9.15).

Vicarious Surgical Price Target by Period

1M3M12M
# Anlaysts111
Avg Price Target$10.50$10.50$10.50
Last Closing Price$9.15$9.15$9.15
Upside/Downside14.75%14.75%14.75%

In the current month, the average price target of Vicarious Surgical stock is $10.50, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 14.75% increase as opposed to Vicarious Surgical's last price of $9.15. This month's average price target is down 0.00% compared to last quarter, and down 0.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Aug 13, 2024Cowen & Co.BuyBuyHold
Jul 18, 2022BTIGBuyBuyHold
May 10, 2022Piper SandlerNeutralNeutralHold
Oct 19, 2021BTIG-BuyInitialise
Row per page
Go to

Vicarious Surgical's last stock rating was published by Cowen & Co. on Aug 13, 2024. The company gave RBOT a "Buy" rating, the same as its previous rate.

Vicarious Surgical Financial Forecast

Vicarious Surgical Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
Revenue-------
Avg Forecast-------
High Forecast-------
Low Forecast-------
# Analysts-------
Surprise %-------

Vicarious Surgical's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. RBOT's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Vicarious Surgical EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
EBITDA-------
Avg Forecast-------
High Forecast-------
Low Forecast-------
Surprise %-------

undefined analysts predict RBOT's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Vicarious Surgical's previous annual EBITDA (undefined) of $NaN.

Vicarious Surgical Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
Net Income-------
Avg Forecast$-15.54M$-16.37M$-16.50M$-16.80M$-14.87M$-15.12M$-15.97M
High Forecast$-15.54M$-16.37M$-16.50M$-16.80M$-14.87M$-14.31M$-15.97M
Low Forecast$-15.54M$-16.37M$-16.50M$-16.80M$-14.87M$-15.88M$-15.97M
Surprise %-------

Vicarious Surgical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. RBOT's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Vicarious Surgical SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
SG&A-------
Avg Forecast-------
High Forecast-------
Low Forecast-------
Surprise %-------

Vicarious Surgical's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to RBOT last annual SG&A of $NaN (undefined).

Vicarious Surgical EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24
# Analysts-------
EPS-------
Avg Forecast$-2.65$-2.79$-2.81$-2.86$-2.53$-2.58$-2.72
High Forecast$-2.65$-2.79$-2.81$-2.86$-2.53$-2.44$-2.72
Low Forecast$-2.65$-2.79$-2.81$-2.86$-2.53$-2.70$-2.72
Surprise %-------

According to undefined Wall Street analysts, Vicarious Surgical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to RBOT previous annual EPS of $NaN (undefined).

Vicarious Surgical Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
NVRONevro$4.45$32.72635.28%Hold
SGHTSight Sciences$3.98$9.00126.13%Hold
MXCTMaxCyte$3.55$8.00125.35%Buy
LUNGPulmonx$6.72$11.9377.53%Buy
PROFProfound Medical$8.17$14.2574.42%Buy
KIDSOrthoPediatrics$24.26$39.6063.23%Buy
RXSTRxSight$44.65$70.1157.02%Buy
SIBNSI-BONE$13.14$20.0052.21%Buy
NPCENeuroPace$9.15$12.8840.77%Buy
OFIXOrthofix Medical$18.64$24.0028.76%-
CNMDCONMED$75.65$96.0026.90%Buy
CTKBCytek Biosciences$6.78$8.5025.37%Buy
CVRXCVRx$14.20$16.3315.00%Buy
FNAParagon 28$10.30$11.5011.65%Buy
RBOTVicarious Surgical$9.15$8.75-4.37%Buy
BVSBioventus$11.16$8.83-20.88%Buy

RBOT Forecast FAQ

Is Vicarious Surgical a good buy?

Yes, according to 3 Wall Street analysts, Vicarious Surgical (RBOT) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of RBOT's total ratings.

What is RBOT's price target?

Vicarious Surgical (RBOT) average price target is $8.75 with a range of $7 to $10.5, implying a -4.37% from its last price of $9.15. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Vicarious Surgical stock go up soon?

According to Wall Street analysts' prediction for RBOT stock, the company can go down by -4.37% (from the last price of $9.15 to the average price target of $8.75), up by 14.75% based on the highest stock price target, and down by -23.50% based on the lowest stock price target.

Can Vicarious Surgical stock reach $14?

RBOT's average twelve months analyst stock price target of $8.75 does not support the claim that Vicarious Surgical can reach $14 in the near future.

What is Vicarious Surgical's current price target trend?

1 Wall Street analyst forecast a $10.5 price target for Vicarious Surgical (RBOT) this month, up 14.75% from its last price of $9.15. Compared to the last 3 and 12 months, the average price target increased by 14.75% and increased by 14.75%, respectively.

What are Vicarious Surgical's analysts' financial forecasts?

Vicarious Surgical's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-45.971M (high $-45.16M, low $-46.724M), average SG&A $0 (high $0, low $0), and average EPS is $-7.828 (high $-7.689, low $-7.956). RBOT's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-65.21M (high $-65.21M, low $-65.21M), average SG&A $0 (high $0, low $0), and average EPS is $-11.103 (high $-11.103, low $-11.103).